HepCAP | NYS Hep C Patient Assistance Program (NYS DOH)
What is HepCAP?
The goal of this program is to ensure that people who are infected with hepatitis C have proper access to medical services related to hepatitis C. HepCAP serves New York State residents infected with Hep C who are uninsured and who meet program eligibility criteria.
- Initial Hep C Medical and Treatment Evaluation
The purpose of this service is to establish the state of Hep C disease, monitor chronic liver disease, such as cirrhosis and liver cancer, and evaluate for and/or initiate Hep C anti-viral therapy.
Services include: brief interim history; limited physical exam; medication administration (i.e. weekly dispensing of hep C pills); side-effect monitoring; hepatitis A and B vaccination series as indicated; liver screening (i.e. ultrasound, blood test or liver biopsy) and laboratory testing (including Hep C RNA and HIV testing).
- Hep C Treatment Monitoring
This service includes on-going monitoring recommended during Hep C treatment and up to six months after treatment is complete.
Services include: brief interim history; limited physical exam; medication administration (i.e., weekly dispensing of Hep C pills if needed); side-effect monitoring; continuation of hepatitis A and B vaccination series as indicated; laboratory testing (including Hep C RNA) and mental health assessments.
NOTE: HepCAP will not cover the costs of the anti-viral therapy, but will help clients to apply to Patient Assistance Programs, available through the pharmaceutical companies currently developing Hep C anti-viral medications.
- Must be infected only with Hep C, and have a positive viral load. Cannot have HIV.
- Live in New York State (may be homeless or undocumented)
- Earn less than 435% of the Federal Poverty Level (FPL) ($44,000 for a household of one person). FPL varies based on household size and is updated annually. Households cannot have liquid assets greater than $25,000. Liquid assets are cash, savings, stocks, bonds, etc. Liquid assets do not include car, home or federally recognized retirement accounts.
Due to limited funding, only those providers funded by the New York State Department of Health AIDS Institute, to integrate hep C care and treatment into primary care settings, will be allowed to enroll patients into the program.
Last Updated on November 12, 2020 by HepFree NYCTags: Hepatitis C